While pharmaceutical research continues to grow steadily, with a forecast compound annual growth rate of over 3% for 2015–2020, the untold story may be the growth in outsourcing to CROs. Frost & Sullivan forecast CRO market penetration will rise from 28.9% in 2015 ($31.8 billion revenue) to 42.6% in 2020 ($56.4 billion revenue). Dr John Moller of Novotech CRO concludes with an examination of the regional CRO alliance model.

Comments are closed.

%d bloggers like this: